Nesheim ME - Search Results

1

The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin.

Walker JB, Nesheim ME. Walker JB, et al. Among authors: nesheim me. J Biol Chem. 1999 Feb 19;274(8):5201-12. doi: 10.1074/jbc.274.8.5201. J Biol Chem. 1999. PMID: 9988770 Free article.

2

A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.

Wang W, Boffa MB, Bajzar L, Walker JB, Nesheim ME. Wang W, et al. Among authors: nesheim me. J Biol Chem. 1998 Oct 16;273(42):27176-81. doi: 10.1074/jbc.273.42.27176. J Biol Chem. 1998. PMID: 9765237 Free article.

3

Proteolytic processing of human coagulation factor IX by plasmin.

Samis JA, Ramsey GD, Walker JB, Nesheim ME, Giles AR. Samis JA, et al. Among authors: nesheim me. Blood. 2000 Feb 1;95(3):943-51. Blood. 2000. PMID: 10648407 Free article.

4

A kinetic analysis of the tissue plasminogen activator and DSPAalpha1 cofactor activities of untreated and TAFIa-treated soluble fibrin degradation products of varying size.

Walker JB, Nesheim ME. Walker JB, et al. Among authors: nesheim me. J Biol Chem. 2001 Feb 2;276(5):3138-48. doi: 10.1074/jbc.M005876200. Epub 2000 Nov 7. J Biol Chem. 2001. PMID: 11069903 Free article.

5

Lipoprotein-complexed C-reactive protein and the biphasic transmittance waveform in critically ill patients.

Nesheim M, Samis J, Walker J, Becker L, Brufatto N, Fischer T, Tejidor L, Jones G, Houdijk W, Giles A, Koschinsky M, Wenstone R, Downey C, Toh CH. Nesheim M, et al. Blood Rev. 2002 Dec;16 Suppl 1:S15-22. Blood Rev. 2002. PMID: 12918783

6

Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin.

Schneider M, Brufatto N, Neill E, Nesheim M. Schneider M, et al. J Biol Chem. 2004 Apr 2;279(14):13340-5. doi: 10.1074/jbc.M313211200. Epub 2004 Jan 8. J Biol Chem. 2004. PMID: 14715654 Free article.

7

Modulation of fibrin cofactor activity in plasminogen activation.

Nesheim M, Walker J, Wang W, Boffa M, Horrevoets A, Bajzar L. Nesheim M, et al. Ann N Y Acad Sci. 2001;936:247-60. doi: 10.1111/j.1749-6632.2001.tb03513.x. Ann N Y Acad Sci. 2001. PMID: 11460482 Review.

8

The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.

Sangrar W, Gabel BR, Boffa MB, Walker JB, Hancock MA, Marcovina SM, Horrevoets AJ, Nesheim ME, Koschinsky ML. Sangrar W, et al. Among authors: nesheim me. Biochemistry. 1997 Aug 26;36(34):10353-63. doi: 10.1021/bi962433d. Biochemistry. 1997. PMID: 9265615

9

Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca(++)-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation.

Toh CH, Samis J, Downey C, Walker J, Becker L, Brufatto N, Tejidor L, Jones G, Houdijk W, Giles A, Koschinsky M, Ticknor LO, Paton R, Wenstone R, Nesheim M. Toh CH, et al. Blood. 2002 Oct 1;100(7):2522-9. doi: 10.1182/blood.V100.7.2522. Blood. 2002. PMID: 12239165 Free article.

10

A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.

Schneider M, Nesheim M. Schneider M, et al. J Biol Chem. 2004 Apr 2;279(14):13333-9. doi: 10.1074/jbc.M313164200. Epub 2004 Jan 8. J Biol Chem. 2004. PMID: 14715655 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page